Arthritis 8 Hour
FDA Label NDC 21130-336

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Safeway Inc. for the product Arthritis 8 Hour (NDC 21130-336). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each caplet), purpose, uses, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Caplet)

Acetaminophen USP, 650 mg

Purpose

Pain reliever/fever reducer

Uses

  • temporarily relieves minor aches and pains due to:
    • muscular aches
    • backache
    • headache
    • toothache
    • minor pain of arthritis
      • temporarily reduces fever

Warnings

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take

  • more than 6 caplets in 24 hours, which is the maximum daily amount
  • with other drugs containing acetaminophen
  • 3 or more alcoholic drinks every day while using this product

Do Not Use

  • with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
  • if you are allergic to acetaminophen or any of the inactive ingredients in this product.
  • if you have difficulty swallowing large tablets or capsules. People over 65 may have difficulty swallowing these tablets.

Ask A Doctor Before Use If You Have

Liver disease.

Ask A Doctor Or Pharmacist Before Use If You Are

Taking the blood thinning drug warfarin.

Stop Use And Ask A Doctor If

  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • new symptoms occur
  • redness or swelling is present
  • These could be signs of a serious condition.

If Pregnant Or Breast-Feeding

Ask a health professional before use.

Keep Out Of Reach Of Children.

Overdose warning: Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions

  • do not take more than directed (see overdose warning)
    adults and children 12 years and overtake 2 caplets every 8 hours with water
    swallow whole - do not crush, chew or dissolve
    do not take more than 6 caplets in 24 hours
    do not use for more than 10 days unless directed by a doctor
    children under 12 yearsdo not use

Other Information

  • store at 20 - 25° C (68 - 77° F). Avoid excessive heat 40° C (104° F).
  • see end panel for batch number and expiration date
  • TAMPER EVIDENT: DO NOT USE IF IMPRINTED SEAL IS BROKEN OR MISSING FROM BOTTLE.

Inactive Ingredients

Croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, propylene glycol, sodium lauryl sulfate, stearic acid, titanium dioxide

Questions?

Call 1-800-406-7984

Principal Display Panel

8 Hour

Use only as directed.

NDC 21130-336-01

Pain Relief

Compare to Tylenol®8 Hour active ingredient

Acetaminophen

Extended-Release Tablets, USP

Pain Reliever/Fever Reducer

  • For up to 8 Hour Relief of Minor Muscle Aches & Pain
  • DO NOT USE WITH OTHER MEDICINES CONTAINING ACETAMINOPHEN

    100 CAPLETS*650 mg EACH(*capsule-shaped tablets)

    SAFEWAY®

    DISTRIBUTED BY SAFEWAY INC.

    5091297/R1011

    This Is The 100 Count Bottle Carton Label For Safeway Arthritis 8 Hour Tablets. (Apap8hour)

    This Is The 100 Count Bottle Carton Label For Safeway Arthritis 8 Hour Tablets. (Apap8hour)

* Please review the disclaimer below.